CCL3 and diffuse large B-cell lymphoma: Among the top ten immune makers correlated with CXCL10, chemokines CCL3 and CCL4 are identified as biomarkers for B cell receptor pathway activation and prognostic serum markers in DLBCL (Takahashi et al., 2015).